AzTrials
AzTrials

Third Molars ExtractionRITORNCT06880952

Effect of Post-operative Chlorhexidine on Postoperative Pain and Complications After Surgical Removal of Mandibular Third Molars

A study testing Chlorhexidine Digluconate Mouthwash without Alcohol in people with Third Molars Extraction, run by Isala at 1 site in Netherlands.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study aimed to assess the impact of postoperative chlorhexidine use on pain management following mandibular third molar removal In this prospective, randomized controlled trial,130 patients who underwent mandibular third molar surgical removal were divided into two groups: one group used chlorhexidine for… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Third Molars Extraction
What is being tested?
Chlorhexidine Digluconate Mouthwash without Alcohol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
145 participants
Where
1 siteNetherlands
Study dates
1 Sep 2021to 19 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • healthy adults (18+) referred by their dentist for third molar removal

Who cannot join

  • active pericoronitis or other infections
  • planned coronectomy
  • trismus
  • chronic pain
  • pregnancy
  • known allergies to local anesthesia

Trial locations and contacts

1 site in 1 country.

Netherlands1 site
  • Isala Hospital

    Zwolle, Overijssel, 8025AB

Other trials in Netherlands

About this study

Official title: Effect of Post-operative Chlorhexidine on Postoperative Pain and Complications After Surgical Removal of Mandibular Third Molars: a Randomized Controlled Trial

This study aimed to assess the impact of postoperative chlorhexidine use on pain management following mandibular third molar removal

In this prospective, randomized controlled trial,130 patients who underwent mandibular third molar surgical removal were divided into two groups: one group used chlorhexidine for postoperative rinsing and the other did not rinse. Pain levels, measured using the Numeric Rating Scale (NRS), were recorded daily for the first seven days post-surgery. Paired-samples t-tests were utilized for data analysis.

Being tested
Chlorhexidine Digluconate Mouthwash without Alcohol
Keywords
third molar, chlorhexidine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Chlorhexidine Digluconate Mouthwash without AlcoholOther

    In the rinsing group, the patients received a bottle of 0,2% chlorhexidine

Study groups in NCT06880952
Study groupRoleWhat they receive
Post-operative rinsing with chlorhexidineOtherIn the rinsing group, the patients received a bottle of 0,2% chlorhexidine
Receives: Other: Chlorhexidine Digluconate Mouthwash without Alcohol
No post-operative rinsingNo interventionThose allocated to the control group received no post-operative rinsing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postoperative pain after removal of third molar

    The primary endpoint is the difference in the postoperative pain measured on a numerical rating scale (NRS) evaluated at seven days

    Measured: 7 days after the inclusion pain was measured on a numerical rating scale

Secondary outcomes (1)
  1. Post-operative complications

    As secondary outcome measures alveolitis, foodimpaction, bleeding or infection

    Measured: 7 days after the treatment the patient was seen at the outpatient clinic for clinical assessment. At this moment the number of patients with alveolitis, foodimpaction and bleeding was scored.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2025
  2. Study start1 Sep 2021
  3. Primary completion24 Mar 2022
  4. Study completion19 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
145 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06880952
Sponsor's protocol ID
71727.075.20
Acronym
RITOR
Status last verified
Mar 2025
First submitted
10 Mar 2025
Last updated
18 Mar 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Ghaeminia H, Hoppenreijs TJ, Xi T, Fennis JP, Maal TJ, Berge SJ, Meijer GJ. Postoperative socket irrigation with drinking tap water reduces the risk of inflammatory complications following surgical removal of third molars: a multicenter randomized trial. Clin Oral Investig. 2017 Jan;21(1):71-83. doi: 10.1007/s00784-016-1751-1. Epub 2016 Feb 27.

    PubMed 26922634

Questions about this trial

What is this clinical trial studying?

A study testing Chlorhexidine Digluconate Mouthwash without Alcohol in people with Third Molars Extraction, run by Isala at 1 site in Netherlands.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Mar 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Netherlands. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postoperative pain after removal of third molar (time frame: 7 days after the inclusion pain was measured on a numerical rating scale). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06880952, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in